Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection
Boland P.,
Meyer J.,
Berger A.,
Cohen S.,
Neuman T.,
Cooper H.,
Olszanski A.,
Davey M.,
Cheng J.,
Lebenthal A.,
Burtness B.,
Scott W.,
Astsaturov I.
Связанные документы (рекомендация CORE)